We hypothesized that ILF2 ASO–resistant cells’ metabolic reprogramming relied on the repair of DNA damage induced by either ILF2 depletion or by the generation of ROS from activated mitochondrial metabolism and that targeting DNA repair proteins involved in these processes could overcome MM cells’ resistance to DNA damage. Here, XRCC6P5 is linked to Miyoshi myopathy.